| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |